Takeda Faces Joint Attack On Entyvio Patents In April
A London judge has told Takeda that it must defend its patents for bowel disease drug Entyvio during a single trial in April, combining attacks against its protections from four different...To view the full article, register now.
Already a subscriber? Click here to view full article